Diabetes management — keeping up to date

The management of type 2 diabetes (T2D) is rapidly evolving with the introduction of an increasing number of new medicines, updating of guidelines and emerging clinical outcome data. Medicine selection for treatment of T2D has become increasingly complex — especially when considering the Pharmaceutical Benefits Scheme subsidy of certain medicine combinations. On the other hand, some things have not changed; optimising glycaemic control, managing risk of complications and promoting a healthy lifestyle are still the cornerstones of diabetes care. Despite the new medicines available for the treatment of T2D, prescribers should continue to individualise their choice of therapy at each point of escalation based on patient and medicine factors.